Tag: anthrax
April 12, 2018
Emergent BioSolutions Announces Successful Completion of Mutual Recognition Procedure for Market Authorization of BioThrax in European Countries
Emergent BioSolutions (NYSE:EBS) announced the successful completion of the Mutual Recognition Procedure (MRP) for market authorization of BioThrax® (Anthrax Vaccine Adsorbed)... January 23, 2018
Altimmune Announces Notice of Allowance on Patent Covering Use of NasoShield in the U.S.
Altimmune (Nasdaq:ALT) a clinical-stage immunotherapeutics company, today announced that it has received a Notice of Allowance from the United States...
April 12, 2017
5 Top Pharma Stocks of Q1 2017 on the TSX
The Investing News Network takes a look at some of the best-performing pharmaceutical stocks on the TSX during the first... March 27, 2017
Allergan and Paratek Show Positive Results For Acne Treatment
Allergan (NYSE:AGN) and Paratek Pharmaceuticals (NASDAQ:PRTK) announced successful initial results for the two and Phase 3 trials of their acne... January 27, 2017
Emergent BioSolutions Receives Approval for Large-Scale Manufacturing of BioThrax
Emergent BioSolutions Inc. (NYSE:EBS) announced today that the Paul-Ehrlich-Institut (PEI), the regulatory agency under the German Federal Ministry of Health,... January 3, 2017
GeoVax Announces Formation of Scientific Advisory Board
GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company specializing in developing human vaccines, announced today the formation of its inaugural... December 13, 2016
